Icon (ICLR) Stock Forecast & Price Target $116.78 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$115.47 -1.31 (-1.12%) As of 05/22/2026 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Icon - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating HoldBased on 17 Analyst RatingsSell3Hold7Buy7 Based on 17 Wall Street analysts who have issued ratings for Icon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 3 have given a sell rating, 7 have given a hold rating, and 7 have given a buy rating for ICLR. Consensus Price Target $145.6724.74% Upside According to the 17 analysts' twelve-month price targets for Icon, the average price target is $145.67. The highest price target for ICLR is $240.00, while the lowest price target for ICLR is $75.00. The average price target represents a forecasted upside of 24.74% from the current price of $116.78. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for ICLR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Icon and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICLR Analyst Ratings Over TimeTypeCurrent Forecast5/25/25 to 5/25/261 Month Ago4/25/25 to 4/25/263 Months Ago2/24/25 to 2/24/261 Year Ago5/25/24 to 5/25/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy7 Buy rating(s)7 Buy rating(s)6 Buy rating(s)7 Buy rating(s)Hold7 Hold rating(s)7 Hold rating(s)10 Hold rating(s)6 Hold rating(s)Sell3 Sell rating(s)3 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$145.67$148.80$157.47$213.08Forecasted Upside24.74% Upside45.64% Upside51.28% Upside66.48% UpsideConsensus RatingHoldHoldHoldModerate Buy ICLR Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ICLR Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Icon Stock vs. The CompetitionTypeIconMedical CompaniesBroader MarketConsensus Rating Score 2.24 2.30 2.52Consensus RatingHoldHoldModerate BuyPredicted Upside24.74% Upside1,718.95% Upside15.09% UpsideNews Sentiment RatingNeutral NewsSee Recent ICLR NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails5/18/2026 JPMorgan Chase & Co.3 of 5 starsCasey WoodringNot RatedLower TargetNeutral$175.00 ➝ $120.00+2.82%5/18/2026 Royal Bank Of Canada3 of 5 starsRyan HalstedNot RatedInitiated CoverageSector Perform$123.00+6.28%5/4/2026 Leerink Partners2 of 5 starsMichael ChernyNot RatedSet Target$125.00+10.77%3/26/2026 BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSean DodgeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$100.00 ➝ $130.00+30.01%3/18/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeHold (C-) ➝ Sell (D+)3/11/2026 CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick DonnellySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetNeutral$200.00 ➝ $120.00+14.55%3/9/2026 BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLuke SergottSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetEqual Weight$200.00 ➝ $120.00+14.16%2/25/2026 Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeHold ➝ Strong Sell2/23/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDavid WindleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet TargetHold ➝ Buy$175.00 ➝ $135.00+35.41%2/18/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCharles RhyeeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeHold ➝ Buy$183.00 ➝ $120.00+35.41% Get the Latest News and Ratings for ICLR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Icon and its competitors with MarketBeat's FREE daily newsletter. 2/17/2026 Rothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJamie ClarkSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet TargetBuy ➝ Neutral$100.00+7.53%2/13/2026 Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingEric ColdwellSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet Target$119.00+26.96%2/12/2026 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingNeutral ➝ Underperform$75.00-43.67%1/9/2026 MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAnn HynesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet Target$216.00+14.76%1/8/2026 Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJailendra SinghSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy ➝ Hold$231.00 ➝ $222.00+9.40%10/24/2025 UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJohn SourbeerSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingSet Target$220.00+24.89%7/25/2025 EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRoss MukenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$170.00 ➝ $240.00+28.37%5/2/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingM. SykesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetNeutral$180.00 ➝ $160.00+9.30%1/14/2025 William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMax SmockSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:58 PM ET. Should I Buy Icon Stock? ICLR Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, May 19, 2026. Please send any questions or comments about these Icon pros and cons to contact@marketbeat.com. Icon Bull Case Here are some ways that investors could benefit from investing in ICON Public Limited: The current stock price is around $124, reflecting a strong market position and potential for growth. ICON Public Limited has received multiple "Buy" ratings from analysts, indicating positive sentiment and confidence in the company's future performance. Institutional investors hold a significant portion of the stock, with over 95% owned by such entities, suggesting strong backing and stability. The company has a solid market capitalization of approximately $9.32 billion, which positions it well for future investments and expansions. Recent upgrades in stock ratings by major brokerages highlight the company's potential for upward price movement, with targets reaching as high as $135. Icon Bear Case Investors should be bearish about investing in ICON Public Limited for these reasons: Despite positive ratings, some analysts have issued "Sell" ratings, indicating concerns about potential downturns in stock performance. The stock has experienced significant price fluctuations, with a one-year high of $211 and a low of $66.57, suggesting volatility that may deter risk-averse investors. Recent price target reductions by analysts could signal a lack of confidence in the stock's short-term performance. The company's P/E ratio of 15.62, while reasonable, may indicate that the stock is not undervalued compared to its peers, limiting upside potential. Market conditions and economic factors could impact the pharmaceutical and biotechnology sectors, which may affect ICON Public Limited's performance. ICLR Forecast - Frequently Asked Questions What is Icon's forecast for 2026? According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Icon is $145.67, with a high forecast of $240.00 and a low forecast of $75.00. Should I buy or sell Icon stock right now? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Icon in the last year. There are currently 3 sell ratings, 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ICLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICLR, but not buy additional shares or sell existing shares. Does Icon's stock price have much upside? According to analysts, Icon's stock has a predicted upside of 24.74% based on their 12-month stock forecasts. Has Icon been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Icon's stock had 2 downgrades and 1 upgrade by analysts. What analysts cover Icon? Icon has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, JPMorgan Chase & Co., Leerink Partners, Royal Bank Of Canada, Weiss Ratings, and Zacks Research in the past 90 days. Do Wall Street analysts like Icon more than its competitors? Analysts like Icon less than other "medical" companies. The consensus rating score for Icon is 2.24 while the average consensus rating score for "medical" companies is 2.30. Learn more on how ICLR compares to other companies. Stock Forecasts and Research Tools Related Companies IQV Stock Forecast TCOM Stock Forecast SUNB Stock Forecast RDDT Stock Forecast FTAI Stock Forecast AER Stock Forecast CPAY Stock Forecast ULS Stock Forecast RBA Stock Forecast KSPI Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Icon RecommendationsRoyal Bank Of CanadaJPMorgan Chase & Co.Leerink PartnersBMO Capital MarketsWeiss RatingsCitigroupBarclaysZacks ResearchJefferies Financial GroupTD CowenRothschild & Co RedburnRobert W. BairdBank of AmericaMizuhoTruist Financial This page (NASDAQ:ICLR) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icon Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Icon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
